Skip to content

Study · Non-randomized trial · 2016

2 results

[EFFECT OF CORTEXIN ON THE QUALITY OF LIFE IN THE EARLY REHABILITATIVE PERIOD AFTER HEMISPHERIC ISCHEMIC STROKE].

Belova LA, Mashin VV, Abramova VV, Proshin AN, Ovsyannikova AN

Klinicheskaia meditsina1 Jan 2016

PMID27459764 (opens in a new tab)DOI10.18821/0023-2149-2016-94-2-138-143 (opens in a new tab)PepBankPUB-27459764
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients after ischemic stroke, repeated cortexin accelerated and improved quality-of-life normalization versus a single course.

    In plain wordsAfter ischemic stroke, repeated cortexin improved quality of life more than a single course.

    Peptide
    Cortexin (cortical polypeptide complex)
    Outcome
    IncreaseQuality of life
    Study

    n: not reported in source

    Comparator
    Single cortexin course
    Outcome group
    Quality of life · Whole body
    Studied dose
    10 mg twice daily · intramuscularAs given in this study (human).

    Source sentences

    Summary
    resulted in the accelerated and more complete normalization of the quality of life in the early rehabilitation petriod (starting from days 21-27 days after the onset of disease) than in the patients given a single course of cortexin therapy or basal treatment alone.
    2 context sentences
    Summary · context
    90 patients were divided into group 1 treated with cortexin (10 mg i/m twice daily (morning and afternoon) in addition to basal treatment, group 2 given the repeated course of the same treatment, and control group (basal therapy alone).
    Summary · context
    The standard SF-36 questionnaire was used to assess the quality of life.
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients after ischemic stroke, repeated cortexin accelerated and improved quality-of-life normalization versus basal treatment alone.

    In plain wordsAfter ischemic stroke, repeated cortexin improved quality of life more than basal treatment alone.

    Peptide
    Cortexin (cortical polypeptide complex)
    Outcome
    IncreaseQuality of life
    Study

    n: not reported in source

    Comparator
    Basal treatment alone
    Outcome group
    Quality of life · Whole body
    Studied dose
    10 mg twice daily · intramuscularAs given in this study (human).

    Source sentences

    Summary
    resulted in the accelerated and more complete normalization of the quality of life in the early rehabilitation petriod (starting from days 21-27 days after the onset of disease) than in the patients given a single course of cortexin therapy or basal treatment alone.
    2 context sentences
    Summary · context
    90 patients were divided into group 1 treated with cortexin (10 mg i/m twice daily (morning and afternoon) in addition to basal treatment, group 2 given the repeated course of the same treatment, and control group (basal therapy alone).
    Summary · context
    The standard SF-36 questionnaire was used to assess the quality of life.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.